BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
Alibaba
BABA
|
+$1.45B |
| 2 |
Visa
V
|
+$458M |
| 3 |
Technology Select Sector SPDR Fund
XLK
|
+$431M |
| 4 |
DuPont de Nemours
DD
|
+$308M |
| 5 |
NVIDIA
NVDA
|
+$299M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
+$705M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$430M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$257M |
| 4 |
Industrial Select Sector SPDR Fund
XLI
|
+$256M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$243M |
Sector Composition
| 1 | Technology | 22.57% |
| 2 | Consumer Discretionary | 13.95% |
| 3 | Healthcare | 10.5% |
| 4 | Financials | 8.72% |
| 5 | Industrials | 6.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1926
WPP
WPP
$5.86B
| $487K | ﹤0.01% |
+9,320
| New | +$487K |
|
1927
ANI Pharmaceuticals
ANIP
$2.12B
| $486K | ﹤0.01% |
9,028
+994
| +12% | +$53.5K |
|
|
AVTA
1928
DELISTED
Avantax, Inc. Common Stock
AVTA
| $483K | ﹤0.01% |
21,594
-11,606
| -35% | -$260K |
|
1929
Corcept Therapeutics
CORT
$7.68B
| $481K | ﹤0.01% |
21,640
-34,678
| -62% | -$772K |
|
|
CIR
1930
DELISTED
CIRCOR International, Inc
CIR
| $479K | ﹤0.01% |
8,487
-5,309
| -38% | -$300K |
|
1931
Stewart Information Services
STC
$2.09B
| $478K | ﹤0.01% |
11,628
-7,196
| -38% | -$296K |
|
1932
Integra LifeSciences
IART
$1.17B
| $478K | ﹤0.01% |
11,612
-3,281
| -22% | -$135K |
|
1933
CVB Financial
CVBF
$2.77B
| $477K | ﹤0.01% |
35,904
-52,009
| -59% | -$691K |
|
1934
EPR Properties
EPR
$4.45B
| $475K | ﹤0.01% |
10,153
-2,174
| -18% | -$102K |
|
1935
National Beverage
FIZZ
$3.67B
| $474K | ﹤0.01% |
9,797
-13,056
| -57% | -$631K |
|
1936
First Merchants
FRME
$2.31B
| $473K | ﹤0.01% |
16,747
-17,608
| -51% | -$497K |
|
|
FLG
1937
Flagstar Financial, Inc.
FLG
$5.27B
| $471K | ﹤0.01% |
13,968
+3,687
| +36% | +$124K |
|
1938
Park National Corp
PRK
$2.72B
| $468K | ﹤0.01% |
4,573
-4,716
| -51% | -$483K |
|
|
MAG
1939
DELISTED
MAG Silver
MAG
| $468K | ﹤0.01% |
42,000
-17,200
| -29% | -$192K |
|
1940
Vanguard Large-Cap ETF
VV
$45.3B
| $468K | ﹤0.01% |
2,307
+2,049
| +794% | +$415K |
|
1941
Kemper
KMPR
$3.35B
| $468K | ﹤0.01% |
9,689
-8,721
| -47% | -$421K |
|
1942
National Bank Holdings
NBHC
$1.46B
| $467K | ﹤0.01% |
16,069
-6,450
| -29% | -$187K |
|
1943
American Axle
AXL
$697M
| $466K | ﹤0.01% |
56,406
-32,694
| -37% | -$270K |
|
1944
BioXcel Therapeutics
BTAI
$49.8M
| $466K | ﹤0.01% |
4,375
-2,736
| -38% | -$292K |
|
1945
Domo
DOMO
$701M
| $466K | ﹤0.01% |
31,785
-8,310
| -21% | -$122K |
|
1946
Ambev
ABEV
$35.9B
| $466K | ﹤0.01% |
146,421
-40,271
| -22% | -$128K |
|
1947
iShares S&P GSCI Commodity-Indexed Trust
GSG
$996M
| $465K | ﹤0.01% |
23,843
-29,402
| -55% | -$573K |
|
1948
Reinsurance Group of America
RGA
$12.7B
| $464K | ﹤0.01% |
3,349
-4,666
| -58% | -$647K |
|
1949
Hope Bancorp
HOPE
$1.4B
| $460K | ﹤0.01% |
54,654
-10,939
| -17% | -$92.1K |
|
1950
Sabesp
SBS
$16B
| $459K | ﹤0.01% |
38,792
-5,044
| -12% | -$59.7K |
|